Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands
Clinical trial NCT03967249 · COMPLETED
Trial details
- NCT number
- NCT03967249
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-25
- Primary completion
- 2022-03-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.